PROVENT Clinical Trial
Study Shows COVID 'Cocktail' Discovered at VUMC Protects Chronically Ill
Sep 10, 2021 at 02:51 pm by Staff
A monoclonal antibody cocktail against the COVID-19 virus discovered at Vanderbilt University Medical Center and developed by AstraZeneca reduced the risk of symptoms in a stu.... Read More